Drugs to Watch 2024: Here are 13 potential blockbuster therapies expected to launch this year
In addition, Clarivate report highlights some new technology platforms that are likely to achieve significant proof of medical use in the market in 2024
Information...
AstraZeneca to stop developing Crohn’s disease drug
British drugmaker AstraZeneca said on Thursday (June 1) it would stop developing its drug brazikumab to treat inflammatory bowel diseases, including Crohn's disease and ulcerative...
Janssen presents study to show long-term safety profile for Stelara®
The latest analysis presented by the Janssen Pharmaceutical Companies of Johnson & Johnson demonstrated long-term safety profile for ustekinumab drug, sold under the brand...